Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing

Epidemiological studies show that non-steroidal anti-inflammatory drugs (NSAIDs) reduce colorectal cancer incidence. We measured the rate ratio for colorectal adenocarcinoma according to dosage and the timing of exposure by means of a case–control study, nested in a non-concurrent cohort linkage stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Collet, J-P, Sharpe, C, Belzile, E, Boivin, J-F, Hanley, J, Abenhaim, L
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374346/
https://www.ncbi.nlm.nih.gov/pubmed/10487613
http://dx.doi.org/10.1038/sj.bjc.6690651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374346/
https://www.ncbi.nlm.nih.gov/pubmed/10487613
http://dx.doi.org/10.1038/sj.bjc.6690651

Ejemplares similares